REL and adult T-cell leukemia/lymphoma: Interestingly, gains of 2p16.1 were also observed in peripheral T cell lymphoma, not otherwise specified (PTCL NOS) [80] and enhanced c-Rel expression was associated with poor response to therapy in adult T-cell leukemia/lymphoma (ATLL) [81].